VERADIGM INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.01 USD | +0.75% |
|
+7.28% | -22.78% |
ETFs positioned on Veradigm Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.50% | 29 M€ | -3.61% | ||
| 0.43% | 27 M€ | -4.60% | - | |
| 0.16% | 45 M€ | +0.10% | ||
| 0.12% | 509 M€ | -.--% | ||
| 0.04% | 10 M€ | +5.55% | ||
| 0.03% | 773 M€ | -.--% | - | |
| 0.03% | 9 M€ | +5.89% | - | |
| 0.02% | 9 M€ | -.--% | - | |
| 0.01% | 117 M€ | +0.34% | - | |
| 0.01% | 8 M€ | +3.29% | - | |
| 0.01% | 18 M€ | +3.29% | - | |
| 0.01% | 33 M€ | +0.41% | - | |
| 0.01% | 147 M€ | +4.59% | - | |
| 0.00% | 18 M€ | +3.41% | - |
Veradigm Inc. is a healthcare data and technology solutions technology company. The Company is focused on research, analytics, and building scalable data-driven solutions. It combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. It also provides full-service revenue cycle management.
Calendar
Related indices
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
7.95
USD
Average target price
15
USD
Spread / Average Target
+88.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.78% | 856M | |
| +4.36% | 32.45B | |
| +12.62% | 7.26B | |
| +20.83% | 3.84B | |
| -11.50% | 3.43B | |
| -26.96% | 1.31B | |
| -34.31% | 1.11B | |
| +4.02% | 919M | |
| -38.17% | 840M | |
| -17.86% | 712M |
- Stock Market
- Equities
- MDRX Stock
- Funds and ETFs Veradigm Inc.
